Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Mitigation of Vascular Permeability Using Bradykinin Receptor Antagonist and Anti-Fibrinolytic Agent in Rats with Polytrauma and Hemorrhagic Shock

Xiaowu Wu, MD MSc, Daniel N. Darlington, PhD, Josue Garciamarcano, Bin Liu, BS, Jeffrey D Keesee, BS, James Bynum, PhD, Andrew P. Cap, MD PhD

Blood (2019) 134 (Supplement_1): 2345.

https://doi.org/10.1182/blood-2019-130278

Published: 2019

Journal Articles

An Institutional Survey of Warfarin Reversal in the Setting of Life-Threatening Bleeds

Ian Garrahy, DO, Tushar Pawar, MD MPH, Anthony Donato, MD, Amber Stevenson, CMA, Daniel Forman, DO

Blood (2019) 134 (Supplement_1): 4981.

https://doi.org/10.1182/blood-2019-129065

Published: 2019

Journal Articles

A Regional Massive Hemorrhage Protocol: Designed with a Modified Delphi Technique to Obtain Consensus

Jeannie Callum, Calvin Yeh, MD PhD, Mark McVey, MD, Andrew Petrosoniak, MD, Stephanie Cope, Troy Thompson, BAHSc, Victoria Chin, Keyvan Karkouti, MD, Avery Nathans, MDMPH PhD, Kimmo Murto, MD, Suzanne Beno, MD, Jacob Pendergrast, MDFRCPC, Andrew McDonald, MDMSc, Neil Adhikari, MDM MSc, Asim Alam, MD, Donald M. Arnold, MD, Lee Barratt, Andrew Beckett, MD, Sue Brenneman, MD, Hina Chaudhry, BSc, Allison Collins, MD, Margaret Harvey, Jacinthe Lampron, MD, Russell MacDonald, MDMPH, Clarita Margarido, MD, Amanda McFarlan, Barto Nascimento, MDMSc, Wendy Owens, Menaka Pai, MSc, MD FRCPC, Sandro Rizoli, MD PhD, Theodora Ruijs, MD, Robert Skeate, PhD, Teresa Skelton, MD, Michelle Sholzberg, MDBSc,FRCPC,MSc, Kelly Syer, Jami-Lynn Viveiros, Josee Theriault, MD, Alan T. Tinmouth, MD FRCPC, Rardi Van Heest, MD, Susan White, Michelle P. Zeller, MD FRCPC, MHPE, Katerina Pavenski, MD

Blood (2019) 134 (Supplement_1): 5792.

https://doi.org/10.1182/blood-2019-121501

Published: 2019

Journal Articles

Practice Patterns and Clinical Outcomes of Platelet Alloimmunization in a Comprehensive Cancer Center

Rohit V Goswamy, MD, Daniel J Tannenbaum, MD, Fleur M. Aung, MD, Cristhiam Mauricio Rojas Hernandez, MD

Blood (2019) 134 (Supplement_1): 1170.

https://doi.org/10.1182/blood-2019-131837

Published: 2019

Journal Articles

SOD3-Mimetic As a Complement for Genetic Therapy in Sickle Cell Disease

Carleton JC Hsia, PhD, Li Ma, PhD

Blood (2018) 132 (Supplement 1): 2355.

https://doi.org/10.1182/blood-2018-99-120287

Published: 2018

Journal Articles

Blood Loss in Rivaroxaban Anticoagulated Pigs with Severe Polytrauma Is Significantly Reduced By Early Therapy with Prothrombin Complex Concentrate

Oliver Grottke, MD PhD MPH, Necib Akman, MD, Till Braunschweig, MD, Markus Honickel, MD, Hugo ten Cate, MD PhD

Blood (2017) 130 (Supplement 1): 2392.

https://doi.org/10.1182/blood.V130.Suppl_1.2392.2392

Published: 2017

Journal Articles

Severe Trauma Leads to a Fall in Intracellular Triphosphates and a Rise in cAMP in Platelets

Daniel N Darlington, PhD, Xiaowu Wu, MD MSc, Andrew P. Cap, MD PhD

Blood (2017) 130 (Supplement 1): 2318.

https://doi.org/10.1182/blood.V130.Suppl_1.2318.2318

Published: 2017

Journal Articles

Use of Hemoglobin Based Oxygen Carrier HBOC-021 (Hemopure) As a Bridge during Emergencies in Patients Unable to Receive Blood Products: Experience at a Tertiary Care Center

Shahla Bari, MD, Marina Rabinovich, PharmD, BCPS, Marjorie Curry, PharmD, BCOP, Sanjay Raj Jain, MD PhD, Lorraine Cafuir, MD

Blood (2017) 130 (Supplement 1): 4926.

https://doi.org/10.1182/blood.V130.Suppl_1.4926.4926

Published: 2017

Journal Articles

Eltrombopag for the Management of Thrombocytopenia Associated with Tyrosine Kinase Therapy in Patients with Chronic Myeloid Leukemia and Myelofibrosis

Abdallah Abou Zahr, Jorge E. Cortes, MD, Srdan Verstovsek, MD PhD, Jairo Matthews, Nitin Jain, MD, Elias J. Jabbour, MD, Guillermo Garcia-Manero, MD, Michael Andreef, MD PhD, Kiran Naqvi, MD, Hagop M. Kantarjian, MD, Gautam Borthakur, MD

Blood (2016) 128 (22): 3062.

https://doi.org/10.1182/blood.V128.22.3062.3062

Published: 2016

Journal Articles

Efficacy of Eculizumab in Gemcitabine-Induced Thrombotic Microangiopathy: Experience of the French Thrombotic Microangiopathies Reference Centre

Maximilien Grall, MD, Francois Provôt, MD, Jean-Philippe Coindre, MD, Claire Pouteil-Noble, MD PhD, Dominique Guerrot, MD PhD, Ygal Benhamou, MD, Dominique Bordessoule, MD PhD, Agnes Veyradier, MD PhD, Paul Coppo, MD PhD, Steven Grange, MD

Blood (2016) 128 (22): 136.

https://doi.org/10.1182/blood.V128.22.136.136

Published: 2016

Journal Articles

Erythromer (EM), a Nanoscale Bio-Synthetic Artificial Red Cell: Proof of Concept and I n Vivo Efficacy Results

Dipanjan Pan, PhD, Stephen Rogers, PhD, Santosh Misra, PhD, Gururaja Vulugundam, PhD, Lisa Gazdzinski, MS, Albert Tsui, PhD, Nikhil Mistry, MS, Ahmed Said, MD PhD, Philip Spinella, MD, Greg Hare, MD PhD, Greg Lanza, MD PhD, Allan Doctor, MD

Blood (2016) 128 (22): 1027.

https://doi.org/10.1182/blood.V128.22.1027.1027

Published: 2016

Journal Articles

Reperfusion Shutdown: Delayed Onset of Fibrinolysis Resistance after Resuscitation from Hemorrhagic Shock Is Associated with Increased Circulating Levels of Plasminogen Activator Inhibitor-1 and Postinjury Complications

Hunter B Moore, MD, Ernest E Moore, MD, Eduardo Gonzalez, MD, Benjamin J Huebner, MD, Forest Sheppard, MD, Anirban Banerjee, PhD, Angela Sauaia, MD PhD, Christopher C. Silliman, MD PhD

Blood (2016) 128 (22): 206.

https://doi.org/10.1182/blood.V128.22.206.206

Published: 2016

Journal Articles

Therapeutic Activity of Peg Albumin in Transgenic Mouse Model of Sickle Cell Disease Is a Function of the Pattern of Pegylation

Devendra Lingojwar, PhD, Savita Bhutoria, PhD, Fantao Meng, PhD, Sangeetha Thangaswamy, PhD, Henny H Billett, MD, Caterina Minniti, MD, Amy Tsai, PhD, Marcos Intaglietta, PhD, Craig A Branch, PhD, Seetharama A Acharya, PhD

Blood (2016) 128 (22): 4848.

https://doi.org/10.1182/blood.V128.22.4848.4848

Published: 2016

Journal Articles

Prothrombin Complex Concentrate Versus Fresh Frozen Plasma for Vitamin K Antagonist Reversal in Acutely Bleeding Patients: A Retrospective Study

Martin H. Ellis, MD, Orly Avnery, MD, Leticia Aizenberg, MD, Muhamad Mahamid, MD

Blood (2016) 128 (22): 3830.

https://doi.org/10.1182/blood.V128.22.3830.3830

Published: 2016

Journal Articles

Markers of Thromboembolic Risk Were Insignificantly Affected By Either Intraosseous or Intravenous Idarucizumab in a Dabigatran-Anticoagulated Porcine Polytrauma Model

Markus Honickel, MD, Akman Necib, MD, Hugo ten Cate, MD PhD, Rolf Rossaint, MD Prof, Oliver Grottke, MD PhD

Blood (2016) 128 (22): 2623.

https://doi.org/10.1182/blood.V128.22.2623.2623

Published: 2016

Journal Articles

Haptoglobin Therapy Prevents Kidney Injury in Stored Blood Resuscitation of Murine Hemorrhagic Shock

Jan A. Graw, MD, Ivy A. Rosales, MD, Yumin Liu, MD, Venkata S. Sabbisetti, PhD, Frank E. Riley, Osher Rechester, Kenneth D. Bloch, MD, H. Shaw Warren, MD, Joseph V. Bonventre, MD, PhD, Warren M. Zapol, MD

Blood (2014) 124 (21): 761.

https://doi.org/10.1182/blood.V124.21.761.761

Published: 2014

Journal Articles

Reversal of Trauma-Induced Bleeding and Anticoagulation with a Dabigatran-Specific Antidote (idarucizumab) As Assessed By Shed and Washed Blood Tests in a Pig Model of Supratherapeutic Anticoagulation and Trauma

Oliver Grottke, MD PhD, Markus Honickel, MD, Johanna Schurer, Joanne van Ryn, PhD

Blood (2014) 124 (21): 4268.

https://doi.org/10.1182/blood.V124.21.4268.4268

Published: 2014

Journal Articles

Global Activation of Coagulation Is the Initiating Event of Acute Coagulopathy of Trauma As Modeled By Hemorrhage and Lower Body Negative Pressure in Baboons

Heather F Pidcoke, MD PhD, Chriselda G Fedyk, MS, Robbie K Montgomery, MS, Carmen Hinojosa-Laborde, PhD, Victor A Convertino, PhD, Robert E Shade, PhD, Andrew P Cap, MDPhD

Blood (2014) 124 (21): 1468.

https://doi.org/10.1182/blood.V124.21.1468.1468

Published: 2014

Journal Articles

A Single Center Retrospective Analysis of Outcomes Following the Use of 4-Factor Prothrombin Complex Concentrate for Warfarin Reversal in Real-Life Settings

Ranjit Joseph, MD, Amanda Strickland, James Burner, MD, Sean Yates, MD, William Tharpe, PharmD, Ravindra Sarode, MD

Blood (2014) 124 (21): 1561.

https://doi.org/10.1182/blood.V124.21.1561.1561

Published: 2014

Journal Articles

Prothrombin Complex Concentrate in Combination with Fibrinogen Plus Tranexamic Acid Is More Effective Than Mono-Therapy with Prothrombin Complex Concentrate in a Dabigatran Anticoagulation Experimental Polytrauma Model

Oliver Grottke, MD PhD, Markus Honickel, MD, Henri M.H. Spronk, PhD, Hugo ten Cate, Joanne van Ryn, PhD, Rolf Rossaint, MD

Blood (2014) 124 (21): 346.

https://doi.org/10.1182/blood.V124.21.346.346

Published: 2014

NARROW

Mitigation of Vascular Permeability Using Bradykinin Receptor Antagonist and Anti-Fibrinolytic Agent in Rats with Polytrauma and Hemorrhagic Shock

An Institutional Survey of Warfarin Reversal in the Setting of Life-Threatening Bleeds

A Regional Massive Hemorrhage Protocol: Designed with a Modified Delphi Technique to Obtain Consensus

Practice Patterns and Clinical Outcomes of Platelet Alloimmunization in a Comprehensive Cancer Center

SOD3-Mimetic As a Complement for Genetic Therapy in Sickle Cell Disease

Blood Loss in Rivaroxaban Anticoagulated Pigs with Severe Polytrauma Is Significantly Reduced By Early Therapy with Prothrombin Complex Concentrate

Severe Trauma Leads to a Fall in Intracellular Triphosphates and a Rise in cAMP in Platelets

Use of Hemoglobin Based Oxygen Carrier HBOC-021 (Hemopure) As a Bridge during Emergencies in Patients Unable to Receive Blood Products: Experience at a Tertiary Care Center

Eltrombopag for the Management of Thrombocytopenia Associated with Tyrosine Kinase Therapy in Patients with Chronic Myeloid Leukemia and Myelofibrosis

Efficacy of Eculizumab in Gemcitabine-Induced Thrombotic Microangiopathy: Experience of the French Thrombotic Microangiopathies Reference Centre

Erythromer (EM), a Nanoscale Bio-Synthetic Artificial Red Cell: Proof of Concept and I n Vivo Efficacy Results

Reperfusion Shutdown: Delayed Onset of Fibrinolysis Resistance after Resuscitation from Hemorrhagic Shock Is Associated with Increased Circulating Levels of Plasminogen Activator Inhibitor-1 and Postinjury Complications

Therapeutic Activity of Peg Albumin in Transgenic Mouse Model of Sickle Cell Disease Is a Function of the Pattern of Pegylation

Prothrombin Complex Concentrate Versus Fresh Frozen Plasma for Vitamin K Antagonist Reversal in Acutely Bleeding Patients: A Retrospective Study

Markers of Thromboembolic Risk Were Insignificantly Affected By Either Intraosseous or Intravenous Idarucizumab in a Dabigatran-Anticoagulated Porcine Polytrauma Model

Haptoglobin Therapy Prevents Kidney Injury in Stored Blood Resuscitation of Murine Hemorrhagic Shock

Reversal of Trauma-Induced Bleeding and Anticoagulation with a Dabigatran-Specific Antidote (idarucizumab) As Assessed By Shed and Washed Blood Tests in a Pig Model of Supratherapeutic Anticoagulation and Trauma

Global Activation of Coagulation Is the Initiating Event of Acute Coagulopathy of Trauma As Modeled By Hemorrhage and Lower Body Negative Pressure in Baboons

A Single Center Retrospective Analysis of Outcomes Following the Use of 4-Factor Prothrombin Complex Concentrate for Warfarin Reversal in Real-Life Settings

Prothrombin Complex Concentrate in Combination with Fibrinogen Plus Tranexamic Acid Is More Effective Than Mono-Therapy with Prothrombin Complex Concentrate in a Dabigatran Anticoagulation Experimental Polytrauma Model

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only